These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24049139)

  • 1. The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study.
    Cash DM; Ridgway GR; Liang Y; Ryan NS; Kinnunen KM; Yeatman T; Malone IB; Benzinger TL; Jack CR; Thompson PM; Ghetti BF; Saykin AJ; Masters CL; Ringman JM; Salloway SP; Schofield PR; Sperling RA; Cairns NJ; Marcus DS; Xiong C; Bateman RJ; Morris JC; Rossor MN; Ourselin S; Fox NC;
    Neurology; 2013 Oct; 81(16):1425-33. PubMed ID: 24049139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study.
    Dean DC; Jerskey BA; Chen K; Protas H; Thiyyagura P; Roontiva A; O'Muircheartaigh J; Dirks H; Waskiewicz N; Lehman K; Siniard AL; Turk MN; Hua X; Madsen SK; Thompson PM; Fleisher AS; Huentelman MJ; Deoni SC; Reiman EM
    JAMA Neurol; 2014 Jan; 71(1):11-22. PubMed ID: 24276092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.
    Ringman JM; O'Neill J; Geschwind D; Medina L; Apostolova LG; Rodriguez Y; Schaffer B; Varpetian A; Tseng B; Ortiz F; Fitten J; Cummings JL; Bartzokis G
    Brain; 2007 Jul; 130(Pt 7):1767-76. PubMed ID: 17522104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease.
    Ryan NS; Keihaninejad S; Shakespeare TJ; Lehmann M; Crutch SJ; Malone IB; Thornton JS; Mancini L; Hyare H; Yousry T; Ridgway GR; Zhang H; Modat M; Alexander DC; Rossor MN; Ourselin S; Fox NC
    Brain; 2013 May; 136(Pt 5):1399-414. PubMed ID: 23539189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.
    Luis EO; Ortega-Cubero S; Lamet I; Razquin C; Cruchaga C; Benitez BA; Lorenzo E; Irigoyen J; ; Pastor MA; Pastor P
    Neurobiol Aging; 2014 Dec; 35(12):2681-2690. PubMed ID: 25027412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations.
    Lee GJ; Lu PH; Medina LD; Rodriguez-Agudelo Y; Melchor S; Coppola G; Braskie MN; Hua X; Apostolova LG; Leow AD; Thompson PM; Ringman JM
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):154-62. PubMed ID: 23085935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers.
    Quiroz YT; Stern CE; Reiman EM; Brickhouse M; Ruiz A; Sperling RA; Lopera F; Dickerson BC
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):556-61. PubMed ID: 23134660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
    Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
    JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion Tensor MRI Structural Connectivity and PET Amyloid Burden in Preclinical Autosomal Dominant Alzheimer Disease: The DIAN Cohort.
    Prescott JW; Doraiswamy PM; Gamberger D; Benzinger T; Petrella JR;
    Radiology; 2022 Jan; 302(1):143-150. PubMed ID: 34636637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study.
    Cash DM; Bocchetta M; Thomas DL; Dick KM; van Swieten JC; Borroni B; Galimberti D; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni GB; Laforce R; Finger E; de Mendonça A; Sorbi S; Rossor MN; Ourselin S; Rohrer JD;
    Neurobiol Aging; 2018 Feb; 62():191-196. PubMed ID: 29172163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease.
    Vilaplana E; Rodriguez-Vieitez E; Ferreira D; Montal V; Almkvist O; Wall A; Lleó A; Westman E; Graff C; Fortea J; Nordberg A
    Neurology; 2020 May; 94(19):e2026-e2036. PubMed ID: 32291295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE epsilon4 carriers.
    Filippini N; Zarei M; Beckmann CF; Galluzzi S; Borsci G; Testa C; Bonetti M; Beltramello A; Ghidoni R; Benussi L; Binetti G; Frisoni GB
    J Magn Reson Imaging; 2009 May; 29(5):1021-6. PubMed ID: 19388128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.
    Quiroz YT; Schultz AP; Chen K; Protas HD; Brickhouse M; Fleisher AS; Langbaum JB; Thiyyagura P; Fagan AM; Shah AR; Muniz M; Arboleda-Velasquez JF; Munoz C; Garcia G; Acosta-Baena N; Giraldo M; Tirado V; Ramírez DL; Tariot PN; Dickerson BC; Sperling RA; Lopera F; Reiman EM
    JAMA Neurol; 2015 Aug; 72(8):912-9. PubMed ID: 26121081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease.
    Spampinato MV; Rumboldt Z; Hosker RJ; Mintzer JE;
    Radiology; 2011 Mar; 258(3):843-52. PubMed ID: 21163916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different patterns of gray matter atrophy in early- and late-onset Alzheimer's disease.
    Möller C; Vrenken H; Jiskoot L; Versteeg A; Barkhof F; Scheltens P; van der Flier WM
    Neurobiol Aging; 2013 Aug; 34(8):2014-22. PubMed ID: 23561509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease.
    Yan S; Zheng C; Paranjpe MD; Li J; Benzinger TLS; Lu J; Zhou Y
    Theranostics; 2020; 10(23):10563-10572. PubMed ID: 32929366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study.
    Weston PS; Nicholas JM; Lehmann M; Ryan NS; Liang Y; Macpherson K; Modat M; Rossor MN; Schott JM; Ourselin S; Fox NC
    Neurology; 2016 Nov; 87(19):2050-2057. PubMed ID: 27733562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.
    Honea RA; Swerdlow RH; Vidoni ED; Burns JM
    Neurology; 2011 Mar; 76(9):822-9. PubMed ID: 21357834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI study.
    Chen Q; Boeve BF; Senjem M; Tosakulwong N; Lesnick T; Brushaber D; Dheel C; Fields J; Forsberg L; Gavrilova R; Gearhart D; Graff-Radford J; Graff-Radford N; Jack CR; Jones D; Knopman D; Kremers WK; Lapid M; Rademakers R; Ramos EM; Syrjanen J; Boxer AL; Rosen H; Wszolek ZK; Kantarci K
    Neurobiol Aging; 2020 Apr; 88():42-50. PubMed ID: 31918955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
    Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.